Dormicum contains the active ingredient midazolam. Therapeutic indications: - As intravenous sedative cover before and during minor medical, dental and surgical procedures such as gastroscopy, endoscopy, cystoscopy, bronchoscopy and cardiac catheterisation. - For sedation by continuous infusion in patients in intensive care. - As an intramuscular premedication for patients with physical status ASA I-IV who are to undergo surgical procedures. - As an alternative intravenous agent for the induction of anaesthesia in high risk and elderly patients, especially where cardiovascular stability is of particular importance. Induction is more reliable when heavy opiate premedication has been administered or when midazolam is given with a narcotic analgesic such as fentanyl.